The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation-Ubiquitylation

Lingkai Gu1, Zhangjin Shen2, Shizhen Shen3

  • 1Zhejiang Key Laboratory of Maternal and Infant Health, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.

Insights

INAVA mRNA in extracellular vesicles promotes ovarian cancer metastasis by activating fibroblasts. Disrupting this interaction offers a potential therapeutic strategy for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ovarian cancer is frequently diagnosed at advanced stages with metastasis.
  • Extracellular vesicles (EVs) are implicated in tumor metastasis, but their specific mRNA functions are underexplored.
  • INAVA mRNA's role in ovarian cancer progression requires further investigation.

Purpose of the Study:

  • To investigate the function of INAVA mRNA within extracellular vesicles in ovarian cancer metastasis.
  • To elucidate the molecular mechanism by which INAVA mRNA promotes ovarian cancer progression.
  • To explore therapeutic strategies targeting the INAVA-mediated pathway.

Main Methods:

  • Analysis of INAVA mRNA expression in plasma- and tissue-derived EVs from ovarian cancer patients.
  • Functional studies using orthotopic xenograft mouse models to assess metastasis.
  • Investigation of molecular interactions involving INAVA, HMGA2, VRK1, TRIM21, and STAT3.
  • Development and testing of a cell-permeable peptide to disrupt INAVA-HMGA2 interaction.

Main Results:

  • Elevated INAVA mRNA expression in EVs from ovarian cancer patients correlates with distant metastasis and poor prognosis.
  • Uptake and translation of INAVA mRNA activate normal ovarian fibroblasts (NOFs), driving peritoneal metastasis.
  • INAVA inhibits HMGA2 phosphorylation by VRK1, preventing TRIM21-mediated degradation and enhancing STAT3 transcription.
  • A peptide disrupting the INAVA-HMGA2 interaction attenuates NOF activation.

Conclusions:

  • INAVA mRNA in EVs is a key driver of ovarian cancer metastasis by activating fibroblasts through a novel molecular pathway.
  • Targeting the INAVA-HMGA2 interaction presents a promising therapeutic avenue for ovarian cancer treatment.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K